Best Warren Buffett Stocks For 2019

The press likes to say that Warren Buffett is a hold-forever investor, but in his 2016 letter, Buffett specifically addresses this misinterpretation.

Sometimes the comments of shareholders or media imply that we will own certain stocks “forever.” It is true that we own some stocks that I have no intention of selling for as far as the eye can see (and we’re talking 20/20 vision). But we have made no commitment that Berkshire (NYSE:BRK.A)(NYSE:BRK.B) will hold any of its marketable securities forever.

Confusion about this point may have resulted from a too-casual reading of Economic Principle 11 on pages 110-111, which has been included in our annual reports since 1983. That principle covers controlled businesses, not marketable securities. This year I’ve added a final sentence to No. 11 to ensure that our owners understand that we regard any marketable security as available for sale, however unlikely such a sale now seems. – BerKshire 2016 letter

Best Warren Buffett Stocks For 2019: Brooks Automation Inc.(BRKS)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market held its own on Tuesday, with major benchmarks generally pushing very slightly higher after their record run over the past few days. Investors were pleased to see positive readings on consumer sentiment in the U.S., as the health of the economic expansion relies largely on the willingness of shoppers to keep spending. In addition, some companies saw their shares rise due to factors specific to their businesses. Yum China Holdings (NYSE:YUMC), Brooks Automation (NASDAQ:BRKS), and Geron (NASDAQ:GERN) were among the best stocks in the market. Here’s why they performed so well.

  • [By Shane Hupp]

    Brooks Automation (NASDAQ:BRKS) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Tuesday.

  • [By Stephan Byrd]

    Shares of Brooks Automation, Inc (NASDAQ:BRKS) have earned an average recommendation of “Buy” from the ten research firms that are presently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $40.67.

Best Warren Buffett Stocks For 2019: MyoKardia, Inc.(MYOK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on MyoKardia (MYOK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Tortoise Investment Management LLC lowered its position in Myokardia Inc (NASDAQ:MYOK) by 33.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,265 shares of the biotechnology company’s stock after selling 1,133 shares during the quarter. Tortoise Investment Management LLC’s holdings in Myokardia were worth $112,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Myokardia Inc (NASDAQ:MYOK) insider June Lee sold 5,000 shares of the stock in a transaction dated Friday, September 21st. The shares were sold at an average price of $63.13, for a total value of $315,650.00. Following the completion of the transaction, the insider now directly owns 5,426 shares of the company’s stock, valued at approximately $342,543.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

  • [By Logan Wallace]

    BidaskClub cut shares of Myokardia (NASDAQ:MYOK) from a strong-buy rating to a buy rating in a research report sent to investors on Thursday morning.

  • [By Logan Wallace]

    Shares of Myokardia Inc (NASDAQ:MYOK) have been assigned an average recommendation of “Buy” from the ten ratings firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $69.50.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Myokardia (MYOK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Warren Buffett Stocks For 2019: Key Technology Inc.(KTEC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Press coverage about Key Technology (NASDAQ:KTEC) has been trending somewhat positive on Monday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Key Technology earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave news coverage about the industrial products company an impact score of 47.5851902672258 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Leave a Reply

Your email address will not be published. Required fields are marked *